11th May 2015 07:00
ECO Animal Health Group plc(AIM: EAH)
ECO RECEIVES AIVLOSIN® AND ECOMECTIN® MARKETING AUTHORISATIONS IN THE UNITED ARAB EMIRATES
ECO is pleased to announce that it has received three marketing authorisations in the United Arab Emirates (UAE) for Aivlosin® Water Soluble Granules for poultry, Ecomectin® Injection and Ecomectin® Horse Paste.
Aivlosin®, ECO’s patented antibacterial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry.
Ecomectin®, ECO’s European range of antiparasitic products includes an injection licensed for the treatment of cattle and sheep, a pour-on for cattle and a paste formulation for horses.
Peter Lawrence, Chairman of ECO, commented, “These marketing authorisations in the UAE, a key member of the Gulf Cooperation Council, should support the process of obtaining further marketing authorisations in the Kingdom of Saudi Arabia which is a very important poultry market. It underlines ECO’s continued commitment to being a major force in the international market for veterinary pharmaceutical products.”
Contacts: | ||||||
ECO Animal Health Group plc | Peter Lawrence | 020 8336 6190 | ||||
Marc Loomes | 020 8447 8899 | |||||
Spiro Financial | Anthony Spiro | 020 8336 6196 | ||||
Peel Hunt LLP | Dan Webster | 020 7418 8900 | ||||
(Nominated Adviser) | ||||||
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Copyright Business Wire 2015
Related Shares:
Eco Animal